You are here

  • Home
  • Archive
  • Volume 5, Issue 11
  • Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective

Article metrics

Article menu
XML
Original research
Cost-effectiveness of new antiviral treatments for non-genotype 1 hepatitis C virus infection in China: a societal perspective

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2023

AbstractFullPdf
Nov 202012812143
Dec 202015614866
Jan 202120020076
Feb 2021898721
Mar 2021626216
Apr 2021555514
May 2021545410
Jun 2021474815
Jul 2021494921
Aug 2021373523
Sep 2021363415
Oct 2021545435
Nov 2021292831
Dec 2021414315
Jan 2022282812
Feb 2022384014
Mar 2022333211
Apr 2022465011
May 2022636616
Jun 202257548
Jul 202236349
Aug 2022383613
Sep 2022262614
Oct 2022474715
Nov 2022696613
Dec 202270685
Jan 2023262721
Feb 2023676110
Mar 202348369
Apr 2023363812
May 2023363312
Jun 202331325
Jul 2023404110
Aug 2023191813
Total18911851634